Auranofin: repurposing an old drug for a golden new age.
about
Determinants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD InvestigationRepositioning approved drugs for the treatment of problematic cancers using a screening approach.Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerAssessment and management of musculoskeletal disorders among patients living with HIV.In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles.Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.Auranofin Inhibits Retinal Pigment Epithelium Cell Survival through Reactive Oxygen Species-Dependent Epidermal Growth Factor Receptor/ Mitogen-Activated Protein Kinase Signaling PathwayAuranofin-loaded nanoparticles as a new therapeutic tool to fight streptococcal infections.Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.Effects of 1,25(OH)₂D₃ on Cancer Cells and Potential Applications in Combination with Established and Putative Anti-Cancer Agents.In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma.DNA or protein? Capillary zone electrophoresis-mass spectrometry rapidly elucidates metallodrug binding selectivity.Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.Peptide protected gold clusters: chemical synthesis and biomedical applications.Immunomodulatory effects of metal salts at sub-toxic concentrations.Cell-mediated anti-Gag immunity in pharmacologically induced functional cure of simian AIDS: a 'bottleneck effect'?The thioredoxin system in breast cancer cell invasion and migrationHeteroleptic Copper(I) Complexes of "Scorpionate" Bis-pyrazolyl Carboxylate Ligand with Auxiliary Phosphine as Potential Anticancer Agents: An Insight into Cytotoxic Mode.Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma.The Quest for Mononuclear Gold(II) and Its Potential Role in Photocatalysis and Drug Action.Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.Selection and characterization of a human ovarian cancer cell line resistant to auranofin.Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.Better living through chemistry: Addressing emerging antibiotic resistance.Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis.Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.Developmental toxicity of auranofin in zebrafish embryos.Gold(i)-BODIPY-imidazole bimetallic complexes as new potential anti-inflammatory and anticancer trackable agents.Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci.Developing a genetic signature to predict drug response in ovarian cancer.Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells.In vitro antineoplastic effects of auranofin in canine lymphoma cells.Evaluating New Compounds to Treat InfectionsDeterminants for Tight and Selective Binding of a Medicinal Dicarbene Gold(I) Complex to a Telomeric DNA G-Quadruplex: a Joint ESI MS and XRD InvestigationPlanarians as models to investigate the bioactivity of gold(I) complexes in vivo
P2860
Q27704204-54248BF7-1491-4E68-9531-050D35EB4570Q29248487-D0B06997-5B07-4949-A24D-C14DC8198C83Q30238915-5923D904-ACB9-449A-9AFE-926BC9E433C4Q30239955-4A8E3A39-8364-4C6F-AECF-FC83C8163C1EQ31148784-B453C3F2-F8B8-49F7-9C2D-5190BACB8E6EQ35861190-35D4DD81-A720-4AFA-9903-DE0DECB01D4AQ36192986-926504F6-1C1C-44E4-85B1-A124692955F3Q36500235-01612F7F-889D-4AC4-8380-7628BDC4B5E8Q37489932-EB7D543A-19E0-40D1-BF73-F394CF99D41AQ37628495-DE1C945E-CCA9-4F22-90D4-8E93747A83C7Q37706134-4C1CC582-6955-45C8-8FBF-E9E6FE91F726Q38287806-5CFCA938-6864-4809-974C-974C66C7A13AQ38777221-F3F832F2-80AB-4A08-8CD4-D9646E1742D3Q38857692-30DDCC7B-86DA-43D0-81D1-E9ECBA72B921Q40514149-3CC61BCD-74BC-49B8-B5CA-BBE352359A8EQ40853026-7B014C19-A575-4B17-9085-9838524D3010Q42003950-A046F1FB-8DEC-46AF-A335-F7449886991CQ42130456-7D6A955F-15D6-40AE-9E00-8FFB8377012DQ43233942-C2BFDB3D-000A-4F94-BF1A-2A72F078E876Q46305008-398215E9-EF3F-4C52-A337-534CCE9D67F3Q47098444-D09AA7B3-9F13-49AA-A40B-D65579911619Q47135396-B6AF32BC-DAC4-427A-8B0B-E9D653BCB78DQ47446573-33F68124-00AE-4817-A0E4-2385857045EBQ48096762-2394E7FA-0514-4F4E-94FC-A5B0FF4F9A46Q48524331-15260F35-3052-4C07-8B2E-8E6F02C1B3EFQ49687144-7492FAA8-E33E-4354-A798-87854593B4F8Q50479237-7DD7F742-C813-45CD-BB86-3AAE8B9FEF0BQ53237013-3CF3ECAA-39FC-403F-BBFC-707CD109E457Q55016563-4442B118-782F-45AE-BB83-39B3FAE7CA34Q55028564-9FA97F81-2C48-4C7F-B4B4-E5653D9A539EQ55281959-160EEB57-0D77-4220-93D6-FFEDF57FEB7EQ55429885-84B7ADC6-21B4-4020-9DBC-1A851080F9C4Q56375673-763FE00E-33C3-4CF9-81C2-AD1FBFEB491DQ57909142-4F75175F-15BE-4699-B38A-38908214E4AEQ58577738-0B194287-52A3-45B0-8C77-99DC587ACC98
P2860
Auranofin: repurposing an old drug for a golden new age.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Auranofin: repurposing an old drug for a golden new age.
@en
type
label
Auranofin: repurposing an old drug for a golden new age.
@en
prefLabel
Auranofin: repurposing an old drug for a golden new age.
@en
P2860
P1433
P1476
Auranofin: repurposing an old drug for a golden new age.
@en
P2093
Christine Roder
Melanie J Thomson
P2860
P356
10.1007/S40268-015-0083-Y
P577
2015-03-01T00:00:00Z